ArticleJournal of virology2025
Porcine hemagglutinating encephalomyelitis virus VW572 (not Gent/PS412 and Labadie) uses the CD81 receptor and MVB-derived exosomal pathway for efficient entry and spread in neuronal cells.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Different replication behavior of a contemporary porcine hemagglutinating encephalomyelitis virus strain Gent/PS412 compared with the historical neurotropic reference strain VW572.Veterinary research · 2026Article
- Interactions between extracellular vesicles and viruses: lessons learned across species and kingdoms.FEMS microbiology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Porcine hemagglutinating encephalomyelitis virus (PHEV) is considered a neurotropic coronavirus that invades the peripheral (PNS) and central (CNS) nervous system of the pig and causes acute encephalomyelitis, also known as "vomiting and wasting disease." Recently, PHEV has been proposed as a potential surrogate virus model to further elucidate the neuropathogenesis of other betacoronaviruses. In this study, we compared key steps in the replication cycle of three distinct PHEV isolates (VW572, Gent/PS412, and Labadie) in mouse neuronal (N2a) cells. We found that PHEV-VW572 replicates more efficiently in these cells compared to the other two isolates. Interestingly, PHEV-VW572 showed high intracellular virus titers without efficient extracellular release. Further investigation revealed that PHEV-VW572, but not PHEV-Gent/PS412, mainly uses multivesicular body (MVB)-derived exosomes for viral egress. Transmission electron microscopy confirmed the presence of complete PHEV-VW572 virions within intracellular vesicles and the release of fused PHEV-exosome structures near the plasma membrane. Finally, we showed that PHEV binding is restricted for all isolates. Still, we demonstrated that only PHEV-VW572 entry into cells is mediated by the tetraspanin CD81 receptor. Overall, these results suggest that PHEV-VW572 uses the MVB-derived exosomal pathway as a strategy to promote efficient infection and overcome the early restriction in neuronal cells. In addition, these findings highlight isolate-specific differences in PHEV neurotropism.IMPORTANCEThe neuropathogenesis of betacoronaviruses remains largely unclear despite the global impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While these viruses are primarily known for their respiratory effects, mounting evidence suggests they can also cause significant neurological complications, ranging from mild symptoms such as headaches to severe outcomes, such as encephalitis and neurological diseases. The exact mechanisms by which coronaviruses affect the nervous system are still not fully understood, which hampers the development of adequate treatments and prevention strategies for these neurological disorders. In this study, we used the porcine hemagglutinating encephalomyelitis virus (PHEV) as a surrogate model for SARS-CoV-2 to further unravel the neuropathogenesis of betacoronaviruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.